AskBio Acquires BrainVectis and Potential Gene Therapy for Huntington’s
News
AskBio announced that it has acquired BrainVectis, a company developing gene therapies for Huntington’s disease and other neurodegenerative conditions. The two companies will work to advance BrainVectis’ gene therapy programs for neurodegenerative diseases associated ... Read more